Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.210
-0.010 (-0.82%)
Jun 5, 2025, 4:00 PM - Market closed
Lucid Diagnostics Employees
Lucid Diagnostics had 72 employees as of December 31, 2024. The number of employees increased by 2 or 2.86% compared to the previous year.
Employees
72
Change (1Y)
2
Growth (1Y)
2.86%
Revenue / Employee
$57,958
Profits / Employee
-$985,208
Market Cap
130.92M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 72 | 2 | 2.86% |
| Dec 31, 2023 | 70 | -4 | -5.41% |
| Dec 31, 2022 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LUCD News
- 9 days ago - Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes - PRNewsWire
- 21 days ago - PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 22 days ago - Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript - Seeking Alpha
- 22 days ago - Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results - PRNewsWire
- 5 weeks ago - PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025 - PRNewsWire
- 5 weeks ago - Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - PRNewsWire
- 6 weeks ago - NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD - PRNewsWire
- 7 weeks ago - Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga